Design of a functionally equivalent nonglycosylated analog of the glycopeptide antibiotic formaecin I

  • Kaur K
  • Pandey S
  • Salunke D
7Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Various nonglycosylated analogs were designed in order to explore the role of glycosylation in formaecin I, an antibacterial glycopeptide of insect origin. The functional behavior of a designed nonglycosylated analog (P 7 ,endo P 8a ,ΔT 11 )formaecin I was found to be similar to that of native glycosylated peptide. Both the peptides showed similar antibacterial activities against Escherichia coli and Salmonella strains. The designed nonglycosylated analog (P 7 ,endo P 8a ,ΔT 11 )formaecin I has low binding affinity to LPS identical to that of native glycopeptide, formaecin I. Both the peptides have similar killing kinetics and are nontoxic to erythrocytes. Formaecin I and designed nonglycosylated (P 7 ,endo P 8a ,ΔT 11 )formaecin I have no definite conformational features associated with them. The glycosylated residue of threonine in formaecin I and proline residues in designed peptide [(P 7 ,endo P 8a ,ΔT 11 )formaecin I], possibly help in stabilizing the correct conformation that facilitates presentation of the peptide to its receptor. It is evident that a functionally equivalent nonglycosylated analog of native glycosylated antibacterial peptide can be designed by strategically modifying the sequence.

Cite

CITATION STYLE

APA

Kaur, K. J., Pandey, S., & Salunke, D. M. (2007). Design of a functionally equivalent nonglycosylated analog of the glycopeptide antibiotic formaecin I. Protein Science, 16(2), 309–315. https://doi.org/10.1110/ps.062581707

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free